1. Home
  2. EVAX vs ARTW Comparison

EVAX vs ARTW Comparison

Compare EVAX & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • ARTW
  • Stock Information
  • Founded
  • EVAX 2008
  • ARTW 1956
  • Country
  • EVAX Denmark
  • ARTW United States
  • Employees
  • EVAX N/A
  • ARTW N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ARTW Industrial Machinery/Components
  • Sector
  • EVAX Health Care
  • ARTW Industrials
  • Exchange
  • EVAX Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • EVAX 8.7M
  • ARTW 8.6M
  • IPO Year
  • EVAX 2021
  • ARTW N/A
  • Fundamental
  • Price
  • EVAX $2.62
  • ARTW $1.80
  • Analyst Decision
  • EVAX Strong Buy
  • ARTW
  • Analyst Count
  • EVAX 3
  • ARTW 0
  • Target Price
  • EVAX $33.33
  • ARTW N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • ARTW 199.7K
  • Earning Date
  • EVAX 03-26-2025
  • ARTW 02-26-2025
  • Dividend Yield
  • EVAX N/A
  • ARTW N/A
  • EPS Growth
  • EVAX N/A
  • ARTW N/A
  • EPS
  • EVAX N/A
  • ARTW N/A
  • Revenue
  • EVAX $3,295,000.00
  • ARTW $25,181,639.00
  • Revenue This Year
  • EVAX $4,845.21
  • ARTW N/A
  • Revenue Next Year
  • EVAX $30.30
  • ARTW N/A
  • P/E Ratio
  • EVAX N/A
  • ARTW N/A
  • Revenue Growth
  • EVAX N/A
  • ARTW N/A
  • 52 Week Low
  • EVAX $2.22
  • ARTW $1.33
  • 52 Week High
  • EVAX $23.70
  • ARTW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • ARTW 45.76
  • Support Level
  • EVAX $2.22
  • ARTW $1.60
  • Resistance Level
  • EVAX $4.05
  • ARTW $1.75
  • Average True Range (ATR)
  • EVAX 1.17
  • ARTW 0.10
  • MACD
  • EVAX 0.00
  • ARTW -0.01
  • Stochastic Oscillator
  • EVAX 6.99
  • ARTW 27.78

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: